Anna Vilamala
Impact in
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
-
- Antibiotic Use and Resistance
Papers in
-
- Antimicrobial Resistance in Staphylococcus 8
- Otolaryngology and Infectious Diseases 1
- Tuberculosis Research and Epidemiology 1
-
- Antibiotic Resistance in Bacteria 3
- Co-authors
- Marian García-Núñez (4 shared papers)Miquel Sabrià (4 shared papers)Esteban Alberto Reynaga (7 shared papers)Cármen Torres (5 shared papers)Pere Roura Poch (1 shared paper)Manuel Quintana (1 shared paper)Ángela Domı́nguez (1 shared paper)Irene Barrabeig (1 shared paper)
- Journals
- Journal of Antimicrobial Chemotherapy (4 papers)International Journal of Infectious Diseases (1 paper)International Journal of Antimicrobial Agents (1 paper)Vaccine (1 paper)Frontiers in Medicine (1 paper)
- Partner nations
- Spain
In The Last Decade
Anna Vilamala
18 papers receiving 338 citations
Peers
Comparison fields: 5 of 36
- Molecular Medicine 97
- Applied Microbiology and Biotechnology 22
- Infectious Diseases 126
- Endocrinology 20
- Epidemiology 63
Countries citing papers authored by Anna Vilamala
This map shows the geographic impact of Anna Vilamala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Vilamala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Vilamala more than expected).
Fields of papers citing papers by Anna Vilamala
This network shows the impact of papers produced by Anna Vilamala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Vilamala. The network helps show where Anna Vilamala may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Vilamala, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 71 | |
| 2 | 2016 | 57 | |
| 3 | 2018 | 41 | |
| 4 | 2019 | 35 | |
| 5 | 2010 | 26 | |
| 6 | 2019 | 21 | |
| 7 | 2021 | 19 | |
| 8 | 2021 | 15 | |
| 9 | 2020 | 13 | |
| 10 | 2017 | 11 | |
| 11 | 2023 | 8 | |
| 12 | 2017 | 7 | |
| 13 | 2021 | 7 | |
| 14 | 2024 | 5 | |
| 15 | 2024 | 5 | |
| 16 | 2003 | 4 | |
| 17 | 2020 | 4 | |
| 18 | 2025 | 1 | |
| 19 | 2025 | 0 |
About Anna Vilamala
Anna Vilamala is a scholar working on Infectious Diseases, Molecular Medicine, Epidemiology, Applied Microbiology and Biotechnology and Endocrinology, having authored 19 papers that have together received 350 indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (8 papers), Antibiotic Resistance in Bacteria (3 papers), Pneumonia and Respiratory Infections (2 papers), Streptococcal Infections and Treatments (1 paper), Otolaryngology and Infectious Diseases (1 paper), Tuberculosis Research and Epidemiology (1 paper), Autoimmune and Inflammatory Disorders Research (1 paper) and Legionella and Acanthamoeba research (1 paper). The work is most often cited by research in Molecular Medicine (97 citations), Applied Microbiology and Biotechnology (22 citations), Infectious Diseases (126 citations), Endocrinology (20 citations) and Epidemiology (63 citations). Anna Vilamala has collaborated with scholars based in Spain. Frequent co-authors include Marian García-Núñez, Miquel Sabrià, Esteban Alberto Reynaga, Cármen Torres, Pere Roura Poch, Manuel Quintana, Ángela Domı́nguez, Irene Barrabeig, Judit Serra-Pladevall and Jordi Altés. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, International Journal of Infectious Diseases, International Journal of Antimicrobial Agents, Vaccine and Frontiers in Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.